PCSK9 Inhibitors Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Key Drug (Praluent® (Alirocumab), Repatha® (Evolocumab), Leqvio® (Inclisiran) and SINTBILO® (Tafolecimab)), Type of Modality (Monoclonal Antibodies and Small Interfering RNA), Type of Application (Primary Hyperlipidemia, Familial Hypercholesterolemia and Cardiovascular Conditions), Distribution Channel, Geographical Regions, and Leading Players